Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew P Leese

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Anticancer Research|July 18, 2008
A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140Paul A Foster, C Stengel, Tauhid Ali, et al.
International Journal of Cancer|March 3, 2004
Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamatesSimon P Newman, Mathew P Leese, Atul Purohit, et al.
Journal of Medicinal Chemistry|August 5, 2005
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agentsMathew P Leese, Hatem A M Hejaz, Mary F Mahon, et al.
Anticancer Research|September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX ExpressionChloe Stengel, Simon P Newman, Mathew P Leese, et al.
Journal of Medicinal Chemistry|March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamateFabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
ACS Medicinal Chemistry Letters|January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule DisruptorsMathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
Biochemical and Biophysical Research Communications|March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitorJulie E Reed, L W Lawrence Woo, James J Robinson, et al.
Breast Cancer Research and Treatment|October 25, 2007
2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo techniquePaul A Foster, Yaik T Ho, Simon P Newman, et al.
Chemmedchem|October 15, 2013
Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptorsMathew P Leese, Fabrice L Jourdan, Meriel R Major, et al.
Organic & Biomolecular Chemistry|October 31, 2008
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modellingFabrice Jourdan, Christian Bubert, Mathew P Leese, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Anticancer Research|July 18, 2008
A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140Paul A Foster, C Stengel, Tauhid Ali, et al.
International Journal of Cancer|March 3, 2004
Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamatesSimon P Newman, Mathew P Leese, Atul Purohit, et al.
Journal of Medicinal Chemistry|August 5, 2005
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agentsMathew P Leese, Hatem A M Hejaz, Mary F Mahon, et al.
Anticancer Research|September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX ExpressionChloe Stengel, Simon P Newman, Mathew P Leese, et al.
Journal of Medicinal Chemistry|March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamateFabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
ACS Medicinal Chemistry Letters|January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule DisruptorsMathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
Biochemical and Biophysical Research Communications|March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitorJulie E Reed, L W Lawrence Woo, James J Robinson, et al.
Breast Cancer Research and Treatment|October 25, 2007
2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo techniquePaul A Foster, Yaik T Ho, Simon P Newman, et al.
Chemmedchem|October 15, 2013
Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptorsMathew P Leese, Fabrice L Jourdan, Meriel R Major, et al.
Organic & Biomolecular Chemistry|October 31, 2008
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modellingFabrice Jourdan, Christian Bubert, Mathew P Leese, et al.
Pageof 4